Therapeutic Effects and Safety of Rhodiola rosea Extract WS® 1375 in Subjects with Life‐stress Symptoms – Results of an Open‐label Study
The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
The trial was conducted to investigate the therapeutic effects and safety of a 4 week treatment with Rhodiola rosea extract WS® 1375 in subjects with life‐stress symptoms. This was a multicentre, non‐randomized, open‐label, single‐arm trial. One hundred and one subjects were enrolled in this clinical study and received the study drug at a dose of 200 mg twice daily for 4 weeks. Assessments with seven questionnaires included Numerical Analogue Scales of Subjective Stress Symptoms, Perceived Stress Questionnaire, Multidimensional Fatigue Inventory 20, Numbers Connecting Test, Sheehan Disability Scale and Clinical Global Impressions to cover various aspects of stress symptoms and adverse events. Invariably, all tests showed clinically relevant improvements with regard to stress symptoms, disability, functional impairment and overall therapeutic effect. Improvements were observed even after 3 days of treatment, as were continuing improvements after 1 and 4 weeks. Rhodiola rosea extract WS® 1375 was safe and generally well tolerated. Adverse events were mostly of mild intensity and no serious adverse events were reported. Rhodiola extract at a dose of 200 mg twice daily for 4 weeks is safe and effective in improving life‐stress symptoms to a clinically relevant degree. Copyright © 2012 John Wiley & Sons, Ltd.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sheehan, D. V., Harnett-Sheehan, K., & Raj, B. A. (1996) · International Clinical Psychopharmacology · doi:10.1097/00004850-199606003-00015 · Cited by 1,440
Development of the perceived stress questionnaire: A new tool for psychosomatic research
Levenstein, S., Prantera, C., Varvo, V., Scribano, M. L., Berto, E., Luzi, C., & Andreoli, A. (1993) · Journal of Psychosomatic Research · doi:10.1016/0022-3999(93)90120-5 · Cited by 985 · cited 4×
“In addition to the overall analysis, the efficacy variables were analysed within subgroups by gender, age, body mass index and baseline scores of PSQ, MFI-20, MDMQ and SDS (separated at the median).”
BackgroundInfluentialNew Substances of Plant Origin Which Increase Nonspecific Resistance
Brekhman, I. I., & Dardymov, I. V. (1969) · Annual Review of Pharmacology · doi:10.1146/annurev.pa.09.040169.002223 · Cited by 595
Acute Rhodiola Rosea Intake Can Improve Endurance Exercise Performance
De Bock, K., Eijnde, B. O., Ramaekers, M., & Hespel, P. (2004) · International Journal of Sport Nutrition and Exercise Metabolism · doi:10.1123/ijsnem.14.3.298 · Cited by 149 · cited 1×
“…has been shown to improve mental work capacity (Saratikov et al., 1968; Darbinyan et al., 2000; Shevtsov et al., 2003), physical work capacity (De Bock et al., 2004), physical and mental capacity during stress (Spasov et al., 2000), symptoms of depression (Darbinyan et al., 2007) and mental…”
Background
Cited by
Medicinal Plants of the Russian Pharmacopoeia; their history and applications
Shikov, A. N., Pozharitskaya, O. N., Makarov, V. G., Wagner, H., Verpoorte, R., & Heinrich, M. (2014) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2014.04.007 · Cited by 337
Plant Adaptogens—History and Future Perspectives
Todorova, V., Ivanov, K., Delattre, C., Nalbantova, V., Karcheva-Bahchevanska, D., & Ivanova, S. (2021) · Nutrients · doi:10.3390/nu13082861 · Cited by 121
An Integrative Approach to HPA Axis Dysfunction: From Recognition to Recovery
Ring, M. (2025) · The American Journal of Medicine · doi:10.1016/j.amjmed.2025.05.044 · Cited by 89
Noah, L., Morel, V., Bertin, C., Pouteau, E., Macian, N., Dualé, C., Pereira, B., & Pickering, G. (2022) · Nutrients · doi:10.3390/nu14091863 · Cited by 27
“Preclinical and clinical data support the stress-lowering effect of rhodiola in acute and chronic stress [8,12,45,46].”
Background
Metadata
- Authors
- Edwards, D., Heufelder, A., & Zimmermann, A.
- Venue
- Phytotherapy Research
- Publisher
- Wiley
- Published
- 2012-01-06
- Volume
- 26
- Issue
- 8
- Pages
- 1220-1225
- ISSN
- 0951-418X (ISSN-L)
- 1099-1573
- OpenAlex
- W1585666504
- Cited by
- 72
- References
- 4
- FWCI
- 1.74
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.